Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Gwen Wyatt on Acupressure for Persistent Cancer-Related Fatigue

      May 3, 2014
      By Gwen Wyatt, PhD, RN
      Video
      Conferences|ONS Annual Congress

      Gwen Wyatt, PhD, RN, Professor, College of Nursing, Michigan State University, discusses a study that looks at acupressure to aid in relieving persistent cancer-related fatigue in breast cancer survivors.

      Gwen Wyatt, PhD, RN, professor in the College of Nursing at Michigan State University, discusses a study that looked at acupressure to aid in relieving persistent cancer-related fatigue in breast cancer survivors.

      Wyatt says before this study was started, researchers completed a pilot study. The pilot study examined two different types of procedures: relaxation and stimulating acupressure. The pilot results showed that stimulating acupressure helped patients with fatigue the most, Wyatt says.

      The current study is testing the ability of both relaxation acupressure and stimulating acupressure to assist with cancer-related fatigue while survivors continue to receive standard medical treatment. There is also a third arm of the study where patients are just receiving the standard medical treatment.

      The study is only looking at breast cancer survivors, where cancer-related fatigue can really linger.

      <<<

      View more from the 2014 ONS Annual Congress

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
      3 experts in this video
      3 experts in this video
      Photo of a white man with curly hair and in front of a blue Oncology Nursing News backdrop
      3 experts in this video
      3 experts in this video
      3 experts in this video
      3 experts in this video
      Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
      Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
      Related Content

      Anatomical image of a person with the gastrointestinal tract highlighted

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      Jordyn Sava
      June 12th 2025
      Article

      Lasting survival benefits vs chemotherapy or monotherapy were achieved with nivolumab and ipilimumab for patients MSI-H/ dMMR metastatic colorectal cancer.


      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      October 2nd 2023
      Podcast

      Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.


      Anatomical graphic of a kidney

      AI Tool May Predict Response, Resistance in Advanced RCC

      Kristie L. Kahl
      June 10th 2025
      Article

      A machine learning model applied to CheckMate 9ER may help predict outcomes and resistance in advanced renal cell carcinoma.


      The Vitals

      Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

      Lindsay Fischer
      June 15th 2023
      Podcast

      Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.


      Image of an anatomical figure on a desk of the female reproductive system

      Pembrolizumab Plus CCRT Could Become SOC in High-Risk Cervical Cancer

      Kristi Rosa
      June 8th 2025
      Article

      Final KEYNOTE-A18 results show sustained survival benefit with pembrolizumab plus concurrent chemoradiation in locally advanced cervical cancer.


      Graphic of blood cells

      Zilovertamab Vedotin Plus R-GemOx Shows Activity in R/R DLBCL

      Silas Inman
      June 7th 2025
      Article

      The ROR1-targeted ADC plus R-GemOx led to a 56.3% ORR in patients with relapsed or refractory diffuse large B-cell lymphoma in waveLINE-003.

      Related Content

      Anatomical image of a person with the gastrointestinal tract highlighted

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      Jordyn Sava
      June 12th 2025
      Article

      Lasting survival benefits vs chemotherapy or monotherapy were achieved with nivolumab and ipilimumab for patients MSI-H/ dMMR metastatic colorectal cancer.


      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      October 2nd 2023
      Podcast

      Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.


      Anatomical graphic of a kidney

      AI Tool May Predict Response, Resistance in Advanced RCC

      Kristie L. Kahl
      June 10th 2025
      Article

      A machine learning model applied to CheckMate 9ER may help predict outcomes and resistance in advanced renal cell carcinoma.


      The Vitals

      Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

      Lindsay Fischer
      June 15th 2023
      Podcast

      Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.


      Image of an anatomical figure on a desk of the female reproductive system

      Pembrolizumab Plus CCRT Could Become SOC in High-Risk Cervical Cancer

      Kristi Rosa
      June 8th 2025
      Article

      Final KEYNOTE-A18 results show sustained survival benefit with pembrolizumab plus concurrent chemoradiation in locally advanced cervical cancer.


      Graphic of blood cells

      Zilovertamab Vedotin Plus R-GemOx Shows Activity in R/R DLBCL

      Silas Inman
      June 7th 2025
      Article

      The ROR1-targeted ADC plus R-GemOx led to a 56.3% ORR in patients with relapsed or refractory diffuse large B-cell lymphoma in waveLINE-003.

      Latest Conference Coverage

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer Mutations

      AI Tool May Predict Response, Resistance in Advanced RCC

      Olanzapine May Reduce Nausea, Vomiting From Radiation

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.